Flippin Pain: A Public Health Campaign Evaluation

An Evaluation of an Online Webinar Aimed at Shifting the Beliefs of the UK Population Regarding Persistent Pain

An online webinar aiming to improve the public beliefs related to persistent pain will be offered to members of the public in the UK via social media and targeted via written invitation to individuals on a waiting list for pain and musculoskeletal services in Ayrshire and Arran, Scotland.

Study Overview

• Status: Not yet recruiting
• Conditions: Pain, Chronic
• Intervention / Treatment: Other: Education

Detailed Description

Flippin Pain is a UK based public health campaign which aims to shift the populations perception related to persistent pain to one that is aligned with contemporary pain science understanding. The webinar will be presented by a panel consisting of people with a history of persistent pain and healthcare professionals with experience of treating persistent pain. The webinar will be advertised on social media. When registrants receive their confirmation email confirming their place they will be notified of of the invitation to participate. This link within the email will take them to an online participant information sheet. Once this is read they may decide to proceed with an online survey which would take 10 minutes to complete. This survey will include some non identifiable demographic data and the Pain Beliefs Questionnaire (PBQ). The PBQ is a validated tool that does not require a license to use. The survey will be administered immediately after the webinar, at 3, 6 and 12 months to assess for longitudinal changes in pain beliefs. Another recruitment strategy will be the posted invitation to individuals on a National health Service waiting list. Both groups will complete the same survey questions. The last question of the survey will request the participants email so that future surveys can be sent and the follow ups linked by participant. Individuals will also be asked within the survey if they consent to further contact about the opportunity to answer questions vie a telephone/online interview related to their experience of the webinar. Purposive sampling will be used to recruit 15-20 individuals for a semi structured interview.

• Study Type: Interventional
• Enrollment (Anticipated): 1000
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Ayrshire And Arran
    • Kilmarnock, Ayrshire And Arran, United Kingdom, KA2 0BE
      • Ayrshire and Arran NHS Scotland
      • Contact: Emma Mair, BSc; Email: emma.mair@nhs.net

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Resident within the United Kingdom
• Over the age of 18 years

Exclusion Criteria:

• Unable to read the English version of the surveys

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Pain science education and self management strategies; The intervention will be educational in the form of the provision of contemporary pain science education and supportive advice from people with a history of persistent pain. The duration of the webinar will be 90 minutes.	Other: Education; An explanation of contemporary pain science and a description of effective treatment strategies used by people with a history of persistent pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain Beliefs Questionnaire	A validated self reported questionnaire	10 minutes to complete
Pain self efficacy questionnaire	A validated self reported questionnaire	10 minutes to complete

Collaborators and Investigators

• Sponsor: Teesside University
• Collaborators: Prof Denis Martin; Prof Cormac Ryan; Gail Sowden

Study record dates

Study Major Dates

• Study Start (Anticipated): August 1, 2021
• Primary Completion (Anticipated): August 1, 2022
• Study Completion (Anticipated): December 1, 2022

Study Registration Dates

• First Submitted: May 23, 2021
• First Submitted That Met QC Criteria: May 23, 2021
• First Posted (Actual): May 26, 2021

Study Record Updates

• Last Update Posted (Actual): May 26, 2021
• Last Update Submitted That Met QC Criteria: May 23, 2021
• Last Verified: May 1, 2021

More Information

Terms related to this study

• Keywords: Education
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Chronic Pain
• Other Study ID Numbers: 6167

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: Non identifiable data may be shared.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No